Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.

Badenhorst, D

Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. [electronic resource] - The pharmacogenomics journal Oct 2007 - 339-45 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1470-269X

10.1038/sj.tpj.6500426 doi


Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Cardiomyopathy, Dilated--drug therapy
Cardiotonic Agents--therapeutic use
Cardiovascular Agents--pharmacology
Case-Control Studies
Digoxin--therapeutic use
Diuretics--therapeutic use
Drug Therapy, Combination
Female
Furosemide--therapeutic use
Gene Frequency
Genetic Predisposition to Disease
Haplotypes
Heart Ventricles--pathology
Humans
Male
Middle Aged
Polymorphism, Restriction Fragment Length
Prospective Studies
Receptors, Adrenergic, beta-2--genetics
Risk Factors
Stroke Volume--drug effects
Systole
Time Factors
Treatment Outcome
Ventricular Function, Left--drug effects
Ventricular Remodeling--drug effects